Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

162.30
+0.17000.10%
Volume:1.09M
Turnover:177.15M
Market Cap:251.73B
PE:24.30
High:164.24
Open:163.66
Low:161.39
Close:162.13
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:1.21
T/O Rate:0.07%
Dividend:3.23
Dividend Rate:1.99%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:5.01
PE(LYR):24.82

Loading ...

Morgan Stanley Remains a Buy on AstraZeneca (AZN)

TIPRANKS
·
Jul 17

AstraZeneca price target lowered to 15,300 GBp at Morgan Stanley

TIPRANKS
·
Jul 17

Astrazeneca PLC Stock Rises Thursday, Outperforms Market

Dow Jones
·
Jul 17

AstraZeneca’s Eluminate-4 Trial Targets High-Risk Diabetes Patients, Raising Long-Term Upside for AZN

TIPRANKS
·
Jul 16

Movement Alert|AstraZeneca Rises 3.07% in Regular Trading, $1.5 Billion Lung Cancer Drug Licensing Deal Boosts Sentiment

Market Focus
·
Jul 15

Dizal Pharmaceutical Announces Uncertainty Regarding the Effectiveness of Its Licensing Agreement with AstraZeneca

Stock News
·
Jul 15

AstraZeneca Advances AZD7760 Trial in Japan, Quietly Expanding Its Infection-Prevention Pipeline

TIPRANKS
·
Jul 15

Astrazeneca Slides Tuesday, Underperforms Market

Dow Jones
·
Jul 15

AstraZeneca to acquire rights to develop, commercialize Zegfrovy for $600M

TIPRANKS
·
Jul 14

Astrazeneca Complements Lung-cancer Franchise with New Licensing Deal

Dow Jones
·
Jul 14

AstraZeneca Licenses Zegfrovy From Dizal in Up to $1.5 Billion Deal

MT Newswires Live
·
Jul 14

Innovative Drug Stock Surges to 20% Daily Limit in 14 Seconds

Deep News
·
Jul 14

AstraZeneca Advances AZD5004 Combo Data With Diabetes Drugs, Offering Subtle Upside for AZN Investors

TIPRANKS
·
Jul 14

Astrazeneca PLC Stock Falls Monday, Underperforms Market

Dow Jones
·
Jul 14

European Equities Traded in US as ADRs Decline

MT Newswires Live
·
Jul 13

Jefferies Reaffirms Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Jul 13

Astrazeneca's Drug Pipeline Looks Full Despite Wainua Setback

Dow Jones
·
Jul 13

AstraZeneca (AZN) Gets a Buy from UBS

TIPRANKS
·
Jul 13

Berenberg Lowers Price Target on AstraZeneca to $214 From $232, Keeps Buy Rating

MT Newswires Live
·
Jul 13

Berenberg Bank Sticks to Its Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Jul 13